BHF Kleinwort Benson Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$7.92M Sell
30,410
-10,885
-26% -$2.88M 0.23% 89
2015
Q4
$12.7M Buy
41,295
+7,148
+21% +$2.05M 0.29% 99
2015
Q3
$9.96M Buy
34,147
+314
+0.9% +$104K 0.39% 70
2015
Q2
$13.7M Sell
33,833
-1,180
-3% -$474K 0.46% 67
2015
Q1
$14.8M Sell
35,013
-7,459
-18% -$2.94M 0.41% 73
2014
Q4
$14.6M Buy
42,472
+1,955
+5% +$632K 0.38% 86
2014
Q3
$10.5M Sell
40,517
-505
-1% -$167K 0.34% 84
2014
Q2
$12.9M Sell
41,022
-3,685
-8% -$1.11M 0.38% 78
2014
Q1
$13.7M Buy
44,707
+14,197
+47% +$4.51M 0.4% 77
2013
Q4
$8.53M Buy
30,510
+24,990
+453% +$6.46M 0.54% 62
2013
Q3
$1.33M Buy
5,520
+5,385
+3,989% +$1.21M 0.18% 102
2013
Q2
$29K Buy
+135
New +$28.8K ﹤0.01% 245

Other funds holding BIIB

BHF Kleinwort Benson Group's BIIB Position: Q1 2016 in Review

BHF Kleinwort Benson Group reduced its Biogen (BIIB) stake by 26% in Q1 2016, selling an estimated $2.88M and leaving 30,410 shares worth $7.92M. The position accounts for 0.23% of the portfolio, ranked #89.

BHF Kleinwort Benson Group first reported a position in BIIB in Q2 2013 and has held it in 12 quarters since. The position peaked at $14.8M in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • BHF Kleinwort Benson Group held 30,410 shares of Biogen worth $7.92M as of Q1 2016.
  • BHF Kleinwort Benson Group sold 10,885 Biogen shares in Q1 2016, an estimated $2.88M.
  • Biogen made up 0.23% of BHF Kleinwort Benson Group's portfolio in Q1 2016, its #89 holding.
  • BHF Kleinwort Benson Group first reported a position in Biogen in Q2 2013 and has held it in 12 quarters since.
  • BHF Kleinwort Benson Group's Biogen position peaked at $14.8M in Q1 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on BHF Kleinwort Benson Group's 13F filing for Q1 2016, filed 9 May 2016.